通化东宝：产品取得注册证，产品名称为“门冬胰岛素注射液”

Group 1 - The core point of the article is that Tonghua Dongbao has received a drug registration certificate for its insulin injection from the Ministry of Public Health and Social Welfare of the Dominican Republic [1] - The product name is "Aspart Insulin Injection" [1] - As of the report, Tonghua Dongbao's market capitalization is 18.1 billion yuan [1] Group 2 - For the first half of 2025, Tonghua Dongbao's revenue composition is as follows: 98.59% from the pharmaceutical industry, 1.27% from other businesses, and 0.14% from the real estate sector [1]